Carvedilol Tablet, Film Coated
Product Images NDC 68001-151

17 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68001-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (Image 01)

Structured Formula For Carvedilol (Image 01)
Chemical structure of carvedilol, showing its molecular components including aromatic rings, hydroxyl groups, and an ether linkage, corresponding to the active ingredient carvedilol.*
FDA Label Image

Figure 1 (Image 04)

Figure 1 (Image 04)
A line graph comparing mortality percentages over a 24-month period between two groups: Placebo and Carvedilol. The vertical axis represents % mortality, ranging from 0 to 30, and the horizontal axis represents time in months. The Carvedilol group shows lower mortality compared to Placebo, with a p-value of 0.0014 indicated.*
FDA Label Image

Figure 2 (Image 05)

Figure 2 (Image 05)
A forest plot illustrating hazard ratios across various subgroups including sex, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use. Each subgroup is represented with a point estimate and confidence intervals, with a vertical line at hazard ratio 1.0 indicating no effect. The chart includes an overall estimate for all patients.*
FDA Label Image

Figure 3 (Image 02)

Figure 3 (Image 02)
A line graph comparing percentage mortality over a 24-month period between Carvedilol and a placebo. The y-axis represents percentage mortality, and the x-axis shows months elapsed. The graph indicates lower mortality percentages for Carvedilol compared to placebo over time, with a p-value of 0.03 noted.*
FDA Label Image

Fig 4 (Fig 4 Update Rev 0226)

Fig 4 (Fig 4 Update Rev 0226)
A forest plot showing hazard ratios with 95% confidence intervals for various subgroups of patients treated with Carvedilol tablets. Subgroups include age, sex, timing post-myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA for MI, chronic heart failure status, diuretic use during MI, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The x-axis ranges from 0.4 to 1.3 for hazard ratios.*
FDA Label Image

Carv (Carvedilol Tabs Usp 3.125 mg 100ct)

Carv (Carvedilol Tabs Usp 3.125 mg 100ct)
Carvedilol Tablets USP 3.125 mg film-coated tablets label, showing the BluePoint Laboratories brand. The label includes storage instructions, usage warnings, and a 100-tablet package count. The label has a barcode and space for lot and expiration information. The design uses black and teal text on a white background with pink and blue accents.*
FDA Label Image

Carv 0623 (Carvedilol Labels 3.125mg 100s Rev 0623.jpg.jpg)

Carv 0623 (Carvedilol Labels 3.125mg 100s Rev 0623.jpg.jpg)
Label for Carvedilol Tablets USP 3.125 mg oral film-coated tablets, package of 100, manufactured by Zydus Lifesciences Ltd. for BluePoint Laboratories. The label includes storage instructions, safety warnings, and dosage information references, with NDC 68001-153-00 and Rx only designation.*
FDA Label Image

Carv 0226 (Carvedilol Tablets Usp 3.125mg 100s Rev 0226)

Carv 0226 (Carvedilol Tablets Usp 3.125mg 100s Rev 0226)
Label for Carvedilol Tablets USP 3.125 mg film-coated tablets by BluePoint Laboratories. The package contains 100 tablets. Includes storage instructions, dosage advisory to consult package insert, safety closure warning, and a barcode. Manufactured by Zydus Pharmaceuticals Ltd., Ahmedabad, India.*
FDA Label Image

Carv 0625 (Carvedilol Tabs Usp 6.25 mg 100ct)

Carv 0625 (Carvedilol Tabs Usp 6.25 mg 100ct)
Carvedilol Tablets, USP 6.25 mg film-coated oral tablets packaging label by BluePoint Laboratories. The label includes dosage strength, quantity of 100 tablets, storage instructions, safety warnings, and NDC code 68001-154-00. It is marked Rx only.*
FDA Label Image

Carv 0623 (Carvedilol Labels 6.25mg 100s Rev 0623.jpg.jpg)

Carv 0623 (Carvedilol Labels 6.25mg 100s Rev 0623.jpg.jpg)
Carvedilol 6.25 mg film-coated tablets label for oral use, displaying a package size of 100 tablets. The label indicates the drug is manufactured by Zydus Lifesciences Ltd., India, for BluePoint Laboratories. It includes storage instructions, dosage reference, safety warnings, and an NDC number 68001-154-00.*
FDA Label Image

Carv 0226 (Carvedilol Tablets Usp 6.25mg 100s Rev 0226)

Carv 0226 (Carvedilol Tablets Usp 6.25mg 100s Rev 0226)
Label for Carvedilol Tablets, USP 6.25 mg film-coated tablets, oral route, marketed by BluePoint Laboratories. The label states packaging contains 100 tablets and includes storage instructions, dosage caution, and product handling warnings. The label also shows the NDC number 68001-154-00 and manufacturer details.*
FDA Label Image

Carvedilol Tabs Usp 12.5mg100ct (Carvedilol Tabs Usp 12.5 mg 100ct)

Carvedilol Tabs Usp 12.5mg100ct (Carvedilol Tabs Usp 12.5 mg 100ct)
Label for Carvedilol Tablets, USP 12.5 mg by BluePoint Laboratories. The film-coated oral tablet packaging indicates a quantity of 100 tablets. The label includes dosage strength, storage instructions, and a barcode, with a purple color accent for the strength designation.*
FDA Label Image

Carv 0623 (Carvedilol Labels 12.5mg 100s Rev 0623.jpg.jpg)

Carv 0623 (Carvedilol Labels 12.5mg 100s Rev 0623.jpg.jpg)
Label for Carvedilol Tablets, USP 12.5 mg, film-coated oral tablets, manufactured by Zydus Lifesciences Ltd. for BluePoint Laboratories. The label indicates prescription only and a count of 100 tablets. It includes storage instructions, safety warnings, and barcode information.*
FDA Label Image

Carv Tabs 0226 (Carvedilol Tablets Usp 12.5mg 100s Rev 0226)

Carv Tabs 0226 (Carvedilol Tablets Usp 12.5mg 100s Rev 0226)
Label for Carvedilol Tablets USP 12.5 mg film-coated tablets by BluePoint Laboratories. The label indicates a package of 100 tablets. It includes storage instructions, dosage strength, manufacturer details, and cautions about safety closures and storage conditions.*
FDA Label Image

Carv 0625 (Carvedilol Tabs Usp 25 mg 100ct)

Carv 0625 (Carvedilol Tabs Usp 25 mg 100ct)
Carvedilol Tablets, USP 25 mg film-coated oral tablets label by BluePoint Laboratories. The label indicates a package size of 100 tablets with NDC 68001-152-00 and includes storage and safety instructions, dosage warnings, and manufacturer information.*
FDA Label Image

Carv 0623 (Carvedilol Labels 25mg 100s Rev 0623)

Carv 0623 (Carvedilol Labels 25mg 100s Rev 0623)
Label for Carvedilol Tablets, USP 25 mg film-coated tablets, oral dosage form. The label indicates a package size of 100 tablets. Manufactured by Zydus Lifesciences Ltd., India, for BluePoint Laboratories. The label includes storage instructions, safety warnings, and the NDC number 68001-152-00. The BluePoint Laboratories logo is displayed on the label.*
FDA Label Image

Carv 0226 (Carvedilol Tablets Usp 25mg 100s Rev 0226)

Carv 0226 (Carvedilol Tablets Usp 25mg 100s Rev 0226)
Carvedilol Tablets USP 25 mg film-coated oral tablets packaging label. The label indicates a package size of 100 tablets and is labeled by BluePoint Laboratories. The label includes dosage strength, storage instructions, and safety warnings. The NDC code 68001-152-00 is visible along with manufacturer information from Zydus Pharmaceuticals Ltd., Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.